JP6346561B2 - Ｎ，ｎ，ｎ−トリアルキルポリマー、その調製方法およびその使用 - Google Patents

Ｎ，ｎ，ｎ−トリアルキルポリマー、その調製方法およびその使用 Download PDF

Info

Publication number
JP6346561B2
JP6346561B2 JP2014515014A JP2014515014A JP6346561B2 JP 6346561 B2 JP6346561 B2 JP 6346561B2 JP 2014515014 A JP2014515014 A JP 2014515014A JP 2014515014 A JP2014515014 A JP 2014515014A JP 6346561 B2 JP6346561 B2 JP 6346561B2
Authority
JP
Japan
Prior art keywords
tmc
trimethylchitosan
degree
chitosan
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2014515014A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014518289A (ja
JP2014518289A5 (https=
Inventor
ギャグノン，ジョナサン
Original Assignee
ライバル，ソシエテ エン コマンダイト
ライバル，ソシエテ エン コマンダイト
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ライバル，ソシエテ エン コマンダイト, ライバル，ソシエテ エン コマンダイト filed Critical ライバル，ソシエテ エン コマンダイト
Publication of JP2014518289A publication Critical patent/JP2014518289A/ja
Publication of JP2014518289A5 publication Critical patent/JP2014518289A5/ja
Application granted granted Critical
Publication of JP6346561B2 publication Critical patent/JP6346561B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Birds (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
JP2014515014A 2011-06-13 2012-06-13 Ｎ，ｎ，ｎ−トリアルキルポリマー、その調製方法およびその使用 Expired - Fee Related JP6346561B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161496225P 2011-06-13 2011-06-13
US61/496,225 2011-06-13
PCT/CA2012/050399 WO2012171125A1 (en) 2011-06-13 2012-06-13 N,n,n-trialkylpolymers, methods of their preparation and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017133777A Division JP2017222869A (ja) 2011-06-13 2017-07-07 Ｎ，ｎ，ｎ−トリアルキルポリマー、その調製方法およびその使用

Publications (3)

Publication Number Publication Date
JP2014518289A JP2014518289A (ja) 2014-07-28
JP2014518289A5 JP2014518289A5 (https=) 2015-07-30
JP6346561B2 true JP6346561B2 (ja) 2018-06-20

Family

ID=47356469

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014515014A Expired - Fee Related JP6346561B2 (ja) 2011-06-13 2012-06-13 Ｎ，ｎ，ｎ−トリアルキルポリマー、その調製方法およびその使用
JP2017133777A Pending JP2017222869A (ja) 2011-06-13 2017-07-07 Ｎ，ｎ，ｎ−トリアルキルポリマー、その調製方法およびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017133777A Pending JP2017222869A (ja) 2011-06-13 2017-07-07 Ｎ，ｎ，ｎ−トリアルキルポリマー、その調製方法およびその使用

Country Status (6)

Country Link
US (1) US9505852B2 (https=)
EP (1) EP2718331B1 (https=)
JP (2) JP6346561B2 (https=)
CA (1) CA2869821C (https=)
ES (1) ES2644138T3 (https=)
WO (1) WO2012171125A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9505852B2 (en) * 2011-06-13 2016-11-29 Rival, Société En Commandite N,N,N-trialkylaminopolymers, methods of their preparation and uses thereof
US20160193244A1 (en) * 2013-08-13 2016-07-07 Seikagaku Corporation Drug containing cationized chitosan
CA2938964A1 (en) * 2014-02-19 2015-08-27 Instytut Biochemii I Biofizyki Polskiej Akademii Nauk Method for synthesis of a biopolymer derivative, a biopolymer derivative and its use
CN106167532B (zh) * 2016-09-27 2018-10-26 江南大学 一种壳聚糖季铵盐的制备方法
CN107163165B (zh) * 2017-06-14 2020-01-31 山东师范大学 一种o-羧甲基-n,n-双链长烷基化壳寡糖及制备方法与应用
WO2019169478A1 (en) * 2018-03-05 2019-09-12 Ovensa Inc. Treatment of protein aggregation diseases using n,n,n-trimethylchitosan
WO2020039463A1 (en) 2018-08-23 2020-02-27 Haskoli Islands Chitosan derivatives and methods for preparing the same
JP7365279B2 (ja) * 2020-03-25 2023-10-19 大日精化工業株式会社 キトサン誘導体の製造方法
JP2021172727A (ja) * 2020-04-24 2021-11-01 大日精化工業株式会社 キトサン誘導体及びその製造方法、ｏ／ｗ型乳化組成物、並びに化粧料
KR102570766B1 (ko) * 2020-12-04 2023-08-24 단국대학교 천안캠퍼스 산학협력단 N,n,n-트리메틸 키토산을 포함하는 스프레이 조성물
CN112651384B (zh) * 2021-01-15 2022-08-16 芜湖美的厨卫电器制造有限公司 用于零冷水燃气热水器的方法、装置、存储介质及处理器
WO2024259525A1 (en) * 2023-06-19 2024-12-26 Societe De Commercialisation Des Produits De La Recherche Appliquee Socpra Sante Et Humaines, S.E.C. Nanoparticles comprising n,n,n-trimethyl chitosan coated with peptide agonists of kinin b1 or b2 and/or peptide antagonists of kinin b1 for transvascular drug delivery across the blood-brain barrier

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744166A (en) 1989-02-25 1998-04-28 Danbiosyst Uk Limited Drug delivery compositions
US6410046B1 (en) 1996-11-19 2002-06-25 Intrabrain International Nv Administering pharmaceuticals to the mammalian central nervous system
GB9710699D0 (en) 1997-05-24 1997-07-16 Danbiosyst Uk Gastro-retentive controlled release system
US6328967B1 (en) 1998-03-12 2001-12-11 Allergenics, Inc. Delivery system to modulate immune response
EP1035137A1 (en) * 1999-03-12 2000-09-13 Pasteur Merieux Serums Et Vaccins Method for the reductive amination of polysaccharides
FR2804317B1 (fr) 2000-01-28 2008-06-13 Rhodia Chimie Sa Compositions cosmetiques comprenant un melange polymere cationique/tensioactif et utilisation dudit melange comme agent structurant
JP3908444B2 (ja) * 2000-07-31 2007-04-25 花王株式会社 糖誘導体の製造法
US6726920B1 (en) 2000-09-22 2004-04-27 Durect Corporation Implantable drug delivery patch
US6444466B1 (en) 2001-05-10 2002-09-03 Isis Pharmaceuticals, Inc. Antisense modulation of helicase-moi expression
US7407943B2 (en) 2001-08-01 2008-08-05 Isis Pharmaceuticals, Inc. Antisense modulation of apolipoprotein B expression
US6824599B2 (en) * 2001-10-03 2004-11-30 The University Of Alabama Dissolution and processing of cellulose using ionic liquids
WO2003054208A2 (en) 2001-12-13 2003-07-03 Ism Biopolymer Inc. Method of modulating release of saccharides and uses thereof
CA2507846A1 (en) 2001-12-14 2003-06-26 Ism Biopolymer Inc. Chitosan oligosaccharides and uses thereof
US20040138119A1 (en) 2002-09-18 2004-07-15 Ingo Tamm Use of hepatitis B X-interacting protein (HBXIP) in modulation of apoptosis
US20060058261A1 (en) 2004-09-15 2006-03-16 Andre Aube Chitin derivatives for hyperlipidemia
US7282194B2 (en) 2004-10-05 2007-10-16 Gp Medical, Inc. Nanoparticles for protein drug delivery
US7291598B2 (en) 2005-01-04 2007-11-06 Gp Medical, Inc. Nanoparticles for protein drug delivery
US7381716B2 (en) 2005-11-21 2008-06-03 Gp Medical, Inc. Nanoparticles for protein drug delivery
WO2007036044A1 (en) 2005-09-28 2007-04-05 Dnp Canada Inc. Combination of polychitosamine and fibrate for the prevention and treatment of hyperlipidemia
EA200870059A1 (ru) 2005-12-16 2008-12-30 ДиЭнПи КЭНАДА ИНК. Производные хитина для применения при гиперлипидемии
WO2008067573A2 (en) * 2006-12-01 2008-06-05 Tshwane University Of Technology Drug delivery system
DK2213678T3 (da) 2007-10-17 2013-12-02 Nippon Steel & Sumikin Chem Co Fremgangsmåde til fremstilling af opløst lignin, saccharidråmateriale og monosaccharidråmateriale såvel som opløst lignin
CN101157735B (zh) * 2007-11-27 2010-09-08 江南大学 一种n,n,n-三甲基壳聚糖硫酸甲酯铵的合成方法
JP2010242020A (ja) * 2009-04-09 2010-10-28 Kazuyuki Umemura 脱ｎ−アセチル体の製造方法
US9505852B2 (en) * 2011-06-13 2016-11-29 Rival, Société En Commandite N,N,N-trialkylaminopolymers, methods of their preparation and uses thereof

Also Published As

Publication number Publication date
JP2014518289A (ja) 2014-07-28
EP2718331B1 (en) 2017-08-02
EP2718331A1 (en) 2014-04-16
CA2869821A1 (en) 2012-12-20
JP2017222869A (ja) 2017-12-21
WO2012171125A1 (en) 2012-12-20
EP2718331A4 (en) 2015-04-15
US20140107329A1 (en) 2014-04-17
US9505852B2 (en) 2016-11-29
ES2644138T3 (es) 2017-11-27
CA2869821C (en) 2018-06-19

Similar Documents

Publication Publication Date Title
JP6346561B2 (ja) Ｎ，ｎ，ｎ−トリアルキルポリマー、その調製方法およびその使用
Chakka et al. Carboxymethylation of polysaccharides: Synthesis and bioactivities
Baldrick The safety of chitosan as a pharmaceutical excipient
Avadi et al. Diethylmethyl chitosan as an antimicrobial agent: Synthesis, characterization and antibacterial effects
Chae et al. Influence of molecular weight on oral absorption of water soluble chitosans
EP1455802B1 (en) Uses of chitosan oligosaccharides
Stepnova et al. New approach to the quaternization of chitosan and its amphiphilic derivatives
US9908947B2 (en) Biotechnological sulphated chondroitin sulphate at position 4 or 6 on the same polysaccharide chain, and process for the preparation thereof
WO2014138897A1 (en) Hyaluronic acid derivatives
Stefan et al. The current view on biological potency of cationically modified chitosan
JP2003048839A (ja) 免疫反応性ＮＯ合成を誘導するｉＮＯＳ酵素を刺激する組成剤およびその製造方法
Younessi et al. Preparation and ex vivo evaluation of TEC as an absorption enhancer for poorly absorbable compounds in colon specific drug delivery
EP2934595A1 (en) Hyaluronic acid - antioxidant conjugates and their uses
US20090239822A1 (en) Process for the preparation of esters of diacerein with hyaluronic acid and pharmaceutical compositions containing such esters
Ponomarev et al. Synthesis of water-soluble chitosan derivatives and their use for the stabilization of liposomal suspensions
JP7851649B2 (ja) コンドロイチン硫酸生体ポリアミン複合体、その調製方法及び用途
WO1998008877A1 (en) Chitosan derivatives, process for producing the same and uses of the same
RU2857664C2 (ru) Биогенный полиаминовый комплекс хондроитинсульфата, способ его получения и его применение
CA2507846A1 (en) Chitosan oligosaccharides and uses thereof
WO2023221977A1 (zh) 一种硫酸软骨素生物多胺复合物、其制备方法及用途
Uglea et al. Polysaccharides as supports for antiviral and antitumoral drugs
HK40090609A (zh) 一种硫酸软骨素生物多胺复合物、其制备方法及用途
HK40090609B (zh) 一种硫酸软骨素生物多胺复合物、其制备方法及用途
US20080182819A1 (en) Chitosan compositions and methods for using chitosan compositions in the treatment of health disorders
FR2952375A1 (fr) Polysaccharides comportant des groupes fonctionnels carboxyles substitues par esterification par un derive d'alcool hydrophobe

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140523

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150610

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150610

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160705

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20160831

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161205

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20170307

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20170707

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180409

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180525

R150 Certificate of patent or registration of utility model

Ref document number: 6346561

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees